# MicrobiomeDrug — Paper Framework

## Paper: Predicting Drug Metabolism Potential from Gut Microbiome Gene Family Abundances: An Agent-Executable Skill

---

## 1. Introduction [FILL-IN]

- **Motivation**: Gut microbiome modulates drug efficacy and toxicity, yet no tool links metagenomic profiles to drug metabolism
- **Gap**: No claw4s tool predicts drug-microbiome interactions from metagenomic data
- **Contribution**: Present MicrobiomeDrug — enzyme abundance profiling + drug interaction prediction

## 2. Background [FILL-IN]

- Human drug metabolism (CYP450, GST, SULT, UGT)
- Gut microbial drug metabolism (bacterial reductases, beta-lactamases)
-现有工具: gutSMACK, MUBII, BiG-MAP

## 3. Methods

### 3.1 Enzyme Family Database
- Curated drug-metabolizing enzyme families
- Pfam-based gene family mapping
- [FILL-IN] Integration with MUBII database

### 3.2 Metagenome Processing
- HUMAnN3 pathway abundance
- Pfam annotation via HMMER
- [FILL-IN] Directfrom-FASTA pipeline

### 3.3 Drug Interaction Scoring
- Per-enzyme abundance scoring
- Drug-enzyme relationship mapping
- Tanimoto similarity between drugs

## 4. Results [FILL-IN]

### 4.1 Validation on Synthetic Data
- Recovery of known enzyme spiked samples

### 4.2 Real Data: [FILL-IN]
- Human Microbiome Project (HMP2)
- IBDMDB dataset
- [FILL-IN] Specific drug predictions

### 4.3 Comparison with Existing Methods
- [FILL-IN] gutSMACK comparison

## 5. Discussion [FILL-IN]

- Limitations: function-only (no strain-level resolution)
- Future: integrate STRONG data for drug depletion predictions

## 6. Conclusion [FILL-IN]

## References [FILL-IN]
